PL2202225T3 - Nowy sposób syntezy iwabradyny i jej soli addycyjnych z kwasem farmaceutycznie dopuszczalnym - Google Patents

Nowy sposób syntezy iwabradyny i jej soli addycyjnych z kwasem farmaceutycznie dopuszczalnym

Info

Publication number
PL2202225T3
PL2202225T3 PL09290990T PL09290990T PL2202225T3 PL 2202225 T3 PL2202225 T3 PL 2202225T3 PL 09290990 T PL09290990 T PL 09290990T PL 09290990 T PL09290990 T PL 09290990T PL 2202225 T3 PL2202225 T3 PL 2202225T3
Authority
PL
Poland
Prior art keywords
pharmaceutically acceptable
acceptable acid
new method
added salts
ivabradine
Prior art date
Application number
PL09290990T
Other languages
English (en)
Inventor
Jean-Louis Peglion
AIMéE DESSINGES
Bernard Serkiz
Jean-Michel Lerestif
Jean-Pierre Lecouve
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40823411&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2202225(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of PL2202225T3 publication Critical patent/PL2202225T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PL09290990T 2008-12-24 2009-12-23 Nowy sposób syntezy iwabradyny i jej soli addycyjnych z kwasem farmaceutycznie dopuszczalnym PL2202225T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0807444A FR2940287B1 (fr) 2008-12-24 2008-12-24 Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable.
EP09290990A EP2202225B1 (fr) 2008-12-24 2009-12-23 Nouveau procédé de synthèse de l'ivabradine et de ses sels d'addition à un acide pharmaceutiquemenet acceptable

Publications (1)

Publication Number Publication Date
PL2202225T3 true PL2202225T3 (pl) 2013-01-31

Family

ID=40823411

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09290990T PL2202225T3 (pl) 2008-12-24 2009-12-23 Nowy sposób syntezy iwabradyny i jej soli addycyjnych z kwasem farmaceutycznie dopuszczalnym

Country Status (35)

Country Link
US (1) US8097720B2 (pl)
EP (1) EP2202225B1 (pl)
JP (1) JP5276579B2 (pl)
KR (1) KR101064413B1 (pl)
CN (1) CN101759643B (pl)
AR (1) AR074845A1 (pl)
AU (1) AU2009245875B2 (pl)
BR (1) BRPI0905147A8 (pl)
CA (1) CA2688815C (pl)
CL (1) CL2009002201A1 (pl)
DK (1) DK2202225T3 (pl)
EA (1) EA016405B1 (pl)
ES (1) ES2398332T3 (pl)
FR (1) FR2940287B1 (pl)
GE (1) GEP20125491B (pl)
HR (1) HRP20121044T1 (pl)
JO (1) JO2807B1 (pl)
MA (1) MA31498B1 (pl)
ME (1) ME02037B (pl)
MX (1) MX2009013480A (pl)
MY (1) MY148288A (pl)
NZ (1) NZ582310A (pl)
PA (1) PA8855501A1 (pl)
PE (1) PE20100487A1 (pl)
PL (1) PL2202225T3 (pl)
PT (1) PT2202225E (pl)
RS (1) RS52542B (pl)
SA (1) SA109310011B1 (pl)
SG (1) SG162671A1 (pl)
SI (1) SI2202225T1 (pl)
TW (1) TWI385153B (pl)
UA (1) UA102518C2 (pl)
UY (1) UY32311A (pl)
WO (1) WO2010072930A1 (pl)
ZA (1) ZA200909109B (pl)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101478855B1 (ko) 2007-05-30 2015-01-02 인드-스위프트 래버러토리즈 리미티드 이바브라딘 히드로클로라이드 및 그의 다형태의 제조방법
US11881307B2 (en) 2012-05-24 2024-01-23 Deka Products Limited Partnership System, method, and apparatus for electronic patient care
US11210611B2 (en) 2011-12-21 2021-12-28 Deka Products Limited Partnership System, method, and apparatus for electronic patient care
US20110313789A1 (en) 2010-01-22 2011-12-22 Deka Products Limited Partnership Electronic patient monitoring system
US10453157B2 (en) 2010-01-22 2019-10-22 Deka Products Limited Partnership System, method, and apparatus for electronic patient care
US11244745B2 (en) 2010-01-22 2022-02-08 Deka Products Limited Partnership Computer-implemented method, system, and apparatus for electronic patient care
US11164672B2 (en) 2010-01-22 2021-11-02 Deka Products Limited Partnership System and apparatus for electronic patient care
US10911515B2 (en) 2012-05-24 2021-02-02 Deka Products Limited Partnership System, method, and apparatus for electronic patient care
CN102464595B (zh) * 2010-11-17 2015-02-25 山东新时代药业有限公司 一种伊伐布雷定中间体的合成方法
FR2971507B1 (fr) * 2011-02-14 2013-01-18 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
EP2495237A1 (en) * 2011-03-04 2012-09-05 Alembic Pharmaceuticals Limited An improved process for the preparation of highly pure ivabradine hydrochloride
FR2984319B1 (fr) * 2011-12-20 2013-12-27 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2984320B1 (fr) * 2011-12-20 2013-11-29 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
US10563681B2 (en) 2011-12-21 2020-02-18 Deka Products Limited Partnership System, method, and apparatus for clamping
CN103848789B (zh) * 2012-11-29 2016-05-18 江苏恒瑞医药股份有限公司 一种伊伐布雷定的制备方法
CN103864690B (zh) * 2014-01-06 2016-09-14 北京莱瑞森医药科技有限公司 伊伐布雷定盐酸盐的s晶型、其制备方法和药物组合物
EP3101010A1 (en) 2015-06-03 2016-12-07 Urquima S.A. New method for the preparation of highly pure ivabradine base and salts thereof
CN113372273B (zh) * 2020-03-10 2023-05-09 鲁南制药集团股份有限公司 一种伊伐布雷定中间体化合物iv
CN113372274B (zh) * 2020-03-10 2023-03-24 鲁南制药集团股份有限公司 一种伊伐布雷定的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2681862B1 (fr) * 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
FR2868775B1 (fr) * 2004-04-13 2008-04-11 Servier Lab Nouveau procede de synthese de derives de la 1,3,4,5- tetrahydro-2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2868777B1 (fr) * 2004-04-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2870537A1 (fr) * 2004-05-19 2005-11-25 Servier Lab Nouveau procede de synthese du (1s)-4,5-dimethoxy-1-(methyl aminomethyl-)-benzocyclobutane et de ses sels d'addition, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
EP2097383B1 (en) * 2006-11-30 2012-02-08 Cadila Healthcare Limited Process for preparation of ivabradine hydrochloride
KR101478855B1 (ko) * 2007-05-30 2015-01-02 인드-스위프트 래버러토리즈 리미티드 이바브라딘 히드로클로라이드 및 그의 다형태의 제조방법

Also Published As

Publication number Publication date
DK2202225T3 (da) 2013-02-11
WO2010072930A1 (fr) 2010-07-01
JO2807B1 (en) 2014-09-15
CA2688815C (fr) 2012-01-31
ME02037B (me) 2013-04-30
NZ582310A (en) 2010-11-26
AU2009245875B2 (en) 2011-02-24
UA102518C2 (ru) 2013-07-25
SG162671A1 (en) 2010-07-29
TWI385153B (zh) 2013-02-11
EA016405B1 (ru) 2012-04-30
US8097720B2 (en) 2012-01-17
MA31498B1 (fr) 2010-07-01
AR074845A1 (es) 2011-02-16
AU2009245875A1 (en) 2010-07-08
KR20100075413A (ko) 2010-07-02
KR101064413B1 (ko) 2011-09-14
FR2940287B1 (fr) 2010-12-24
MY148288A (en) 2013-03-29
CN101759643A (zh) 2010-06-30
SI2202225T1 (sl) 2013-01-31
CN101759643B (zh) 2012-05-16
BRPI0905147A2 (pt) 2011-03-22
PA8855501A1 (es) 2010-07-27
EP2202225B1 (fr) 2012-10-24
HK1145833A1 (en) 2011-05-06
EA200901563A1 (ru) 2010-06-30
TW201028385A (en) 2010-08-01
ZA200909109B (en) 2010-09-29
MX2009013480A (es) 2010-06-23
BRPI0905147A8 (pt) 2021-04-06
HRP20121044T1 (hr) 2013-01-31
PT2202225E (pt) 2012-11-15
US20100160628A1 (en) 2010-06-24
EP2202225A1 (fr) 2010-06-30
SA109310011B1 (ar) 2013-04-30
JP5276579B2 (ja) 2013-08-28
ES2398332T3 (es) 2013-03-15
RS52542B (sr) 2013-04-30
UY32311A (es) 2010-06-30
GEP20125491B (en) 2012-04-25
PE20100487A1 (es) 2010-07-22
CA2688815A1 (fr) 2010-06-24
CL2009002201A1 (es) 2010-10-29
JP2010150259A (ja) 2010-07-08
FR2940287A1 (fr) 2010-06-25

Similar Documents

Publication Publication Date Title
PL2202225T3 (pl) Nowy sposób syntezy iwabradyny i jej soli addycyjnych z kwasem farmaceutycznie dopuszczalnym
IL219796A0 (en) Method for producing 5,5-disubstituted 4,5-dihydroisoxazol-3-thiocarboxamidine salts
EP2116575A4 (en) PROCESS FOR PRODUCING POLYLACTIC ACID
EP2175029A4 (en) PROCESS FOR PRODUCING LACTIC ACID
EP2196534A4 (en) RECOMBINANT MICROORGANISM AND METHOD FOR PRODUCING POLY GAMMA GLUTAMINE ACID
MA31149B1 (fr) Nouveau procede de preparation de benzocyclobutenes fonctionnalises, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutique acceptable
EP2436443A4 (en) PROCESS FOR PRODUCING CATALYST FOR PRODUCING METHACRYLIC ACID, AND PROCESS FOR PRODUCING METHACRYLIC ACID
LT2236610T (lt) Patobulintas promotorius ir jo panaudojimas l-lizino gamybos būdui
ZA201105172B (en) New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
IL220851A0 (en) Method for preparing tetrazole methanesulfonic acid salts, and compounds used in same
IL217656A (en) Method for producing 1,1,3-trichloro-1-propane
PT2427654T (pt) Método para edificação de uma torre e torre
ZA201201329B (en) New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
SI2487158T1 (sl) Nov postopek sinteze ivabradina in njegovih dodatnh soli s farmacevstsko sprejemljivo kislino
IL210278A0 (en) Method for producing 3 - methyl - 2 - thiophenecarboxylic acid
ZA201002121B (en) Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
SG10201400650QA (en) Method For Producing L-Amino Acid
SI2607353T1 (sl) Nov postopek sintetize ivabradina in njegovih dodatnih soli s farmacevtsko sprejemljivo kislino
PL2364972T3 (pl) Nowy sposób syntezy iwabradyny i jej soli addycyjnych
PL2268427T3 (pl) Sposób eksploatacji walcowni ziemnej o ulepszonej dynamice
EP2401446A4 (en) COMPONENT AND METHOD FOR PRODUCING THE ELEMENT
LT2803659T (lt) 3,4-dimetoksibiciklo[4.2.0]okta-1,3,5-trien-7-karbonitrilo sintezės būdas ir panaudojimas ivabradino ir jo prisijungimo druskų su farmaciniu požiūriu priimtinomis rūgštimis sintezei
PL2719689T3 (pl) Nowy sposób syntezy (3-(2-bromo-4,5-dimetoksyfenylo)propanonitrylu i zastosowanie do syntezy iwabradyny i jej soli addycyjnych z farmaceutycznie dopuszczalnym kwasem
EP2271194A4 (en) HOUSING MOUNTING STRUCTURE, HOUSING AND HOUSING MOUNTING METHOD
EP2287146A4 (en) PROCESS FOR THE PREPARATION OF OREGANIC ACID